Literature DB >> 18061537

A fingerprint left by cytomegalovirus infection in the human T cell compartment.

Pablo J E J van de Berg1, Amber van Stijn, Ineke J M Ten Berge, René A W van Lier.   

Abstract

Latent infection with human cytomegalovirus (HCMV) is accompanied by a strong increase in the number of resting, effector-type CD4+ and CD8+ T cells with constitutive cytolytic activity in the circulation. Longitudinal studies in kidney transplant recipients revealed that effector cells emerge early after the initial viral burst and acquire their stable phenotype in the months following primary infection. Although it is yet unsettled whether these cells are all specific for CMV encoded or induced antigens, it has become clear that T cell responses to CMV are among the broadest and strongest analyzed so far. We will here summarize the qualities of the effector-type cells found in HCMV carriers and discuss their possible role in CMV-associated pathologies.

Entities:  

Mesh:

Year:  2007        PMID: 18061537     DOI: 10.1016/j.jcv.2007.10.016

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  31 in total

1.  Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation.

Authors:  Kirsten M L Hertoghs; Perry D Moerland; Amber van Stijn; Ester B M Remmerswaal; Sila L Yong; Pablo J E J van de Berg; S Marieke van Ham; Frank Baas; Ineke J M ten Berge; René A W van Lier
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 2.  The role of the T cell in age-related inflammation.

Authors:  Richard Macaulay; Arne N Akbar; Sian M Henson
Journal:  Age (Dordr)       Date:  2012-01-15

Review 3.  The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Miriam Ciáurriz; Amaya Zabalza; Lorea Beloki; Cristina Mansilla; Estela Pérez-Valderrama; Mercedes Lachén; Eva Bandrés; Eduardo Olavarría; Natalia Ramírez
Journal:  Cell Mol Life Sci       Date:  2015-07-15       Impact factor: 9.261

4.  The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.

Authors:  Julia Hornig; K Yeon Choi; Alistair McGregor
Journal:  Virology       Date:  2017-02-10       Impact factor: 3.616

5.  Mechanisms modulating immune clearance during human cytomegalovirus latency.

Authors:  Barry Slobedman; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

6.  Cytomegalovirus-induced effector T cells cause endothelial cell damage.

Authors:  Pablo J E J van de Berg; Si-La Yong; Ester B M Remmerswaal; René A W van Lier; Ineke J M ten Berge
Journal:  Clin Vaccine Immunol       Date:  2012-03-07

7.  Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.

Authors:  Raphaëlle Riou; Céline Bressollette-Bodin; David Boutoille; Katia Gagne; Audrey Rodallec; Maeva Lefebvre; François Raffi; David Senitzer; Berthe-Marie Imbert-Marcille; Christelle Retière
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

8.  Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.

Authors:  Sara Cantisán; Julián Torre-Cisneros; Rosario Lara; Alberto Rodríguez-Benot; Francisco Santos; Juan Gutiérrez-Aroca; Inmaculada Gayoso; Marcelino González-Padilla; Manuel Casal; Antonio Rivero; Rafael Solana
Journal:  Clin Vaccine Immunol       Date:  2009-08-05

9.  The immune response to human CMV.

Authors:  Corinna La Rosa; Don J Diamond
Journal:  Future Virol       Date:  2012-03-01       Impact factor: 1.831

10.  Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies.

Authors:  Peter D Burbelo; Alexandra T Issa; Kathryn H Ching; Maurice Exner; W Lawrence Drew; Harvey J Alter; Michael J Iadarola
Journal:  Virol J       Date:  2009-05-01       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.